These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. [Variability of the clinical expression of Ecstasy-induced hepatotoxicity]. Núñez O; Bañares R; Barrio J; Menchén L; Diego Ad; Salinero E; Clemente G Gastroenterol Hepatol; 2002 Oct; 25(8):497-500. PubMed ID: 12361531 [TBL] [Abstract][Full Text] [Related]
18. [MARS (Molecular Adsorbent Recycling System) as a novel hepatic detoxification procedure until orthotopic liver transplantation]. Ullerich H; Avenhaus W; Menzel J; Dietl KH; Domschke W; Lerch MM Z Gastroenterol; 2001 Dec; 39(12):1023-6. PubMed ID: 11753787 [TBL] [Abstract][Full Text] [Related]
19. Death from hyponatraemia-induced cerebral oedema associated with MDMA ("Ecstasy") use. O'Connor A; Cluroe A; Couch R; Galler L; Lawrence J; Synek B N Z Med J; 1999 Jul; 112(1091):255-6. PubMed ID: 10448984 [No Abstract] [Full Text] [Related]
20. Liver transplantation for ecstasy-induced fulminant hepatic failure. De Carlis L; De Gasperi A; Slim AO; Giacomoni A; Corti A; Mazza E; Di Benedetto F; Lauterio A; Arcieri K; Maione G; Rondinara GF; Forti D Transplant Proc; 2001 Aug; 33(5):2743-4. PubMed ID: 11498145 [No Abstract] [Full Text] [Related] [Next] [New Search]